These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33113127)

  • 1. Study of Candesartan Cilexetil: 2-Hydroxypropyl-β-Cyclodextrin Interactions: A Computational Approach Using Steered Molecular Dynamics Simulations.
    Kiriakidi S; Mavromoustakos T
    Methods Mol Biol; 2021; 2207():45-70. PubMed ID: 33113127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host-Guest Interactions between Candesartan and Its Prodrug Candesartan Cilexetil in Complex with 2-Hydroxypropyl-β-cyclodextrin: On the Biological Potency for Angiotensin II Antagonism.
    Ntountaniotis D; Andreadelis I; Kellici TF; Karageorgos V; Leonis G; Christodoulou E; Kiriakidi S; Becker-Baldus J; Stylos EK; Chatziathanasiadou MV; Chatzigiannis CM; Damalas DE; Aksoydan B; Javornik U; Valsami G; Glaubitz C; Durdagi S; Thomaidis NS; Kolocouris A; Plavec J; Tzakos AG; Liapakis G; Mavromoustakos T
    Mol Pharm; 2019 Mar; 16(3):1255-1271. PubMed ID: 30681344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of solubility and permeability of Candesartan cilexetil by using different pharmaceutical interventions.
    Shaikh SM; Avachat AM
    Curr Drug Deliv; 2011 Jul; 8(4):346-53. PubMed ID: 21453263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S; Reddy VA; Arora S; Patel K
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubility Enhancement of Myricetin by Inclusion Complexation with Heptakis-
    Han D; Han Z; Liu L; Wang Y; Xin S; Zhang H; Yu Z
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cyclodextrins on the solubility and stability of candesartan cilexetil in solution and solid state.
    Al Omari AA; Al Omari MM; Badwan AA; Al-Sou'od KA
    J Pharm Biomed Anal; 2011 Feb; 54(3):503-9. PubMed ID: 20971593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying Different Techniques to Improve the Bioavailability of Candesartan Cilexetil Antihypertensive Drug.
    Aly UF; Sarhan HA; Ali TFS; Sharkawy HAE
    Drug Des Devel Ther; 2020; 14():1851-1865. PubMed ID: 32523332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Pharmaceutical Evaluation of Candesartan and Candesartan Cilexetil: Physicochemical Properties, In Vitro Dissolution and Ex Vivo In Vivo Studies.
    Amer AM; Allam AN; Abdallah OY
    AAPS PharmSciTech; 2018 Feb; 19(2):661-667. PubMed ID: 28948575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphic and Quantum Chemistry Characterization of Candesartan Cilexetil: Importance for the Correct Drug Classification According to Biopharmaceutics Classification System.
    de Campos DP; Silva-Barcellos NM; Lima RR; Savedra RML; Siqueira MF; Yoshida MI; da Nova Mussel W; de Souza J
    AAPS PharmSciTech; 2018 Oct; 19(7):3019-3028. PubMed ID: 30062540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly robust quantum mechanics and umbrella sampling studies on inclusion complexes of curcumin and β-cyclodextrin.
    Kumar P; Bhardwaj VK; Purohit R
    Carbohydr Polym; 2024 Jan; 323():121432. PubMed ID: 37940299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Self-Nanoemulsifying Drug Delivery System for Enhancing the Oral Bioavailability of Candesartan Cilexetil: Ex Vivo and In Vivo Evaluation.
    AboulFotouh K; Allam AA; El-Badry M; El-Sayed AM
    J Pharm Sci; 2019 Nov; 108(11):3599-3608. PubMed ID: 31348934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study on inclusion complex formation between formononetin and β-cyclodextrin derivatives through multiscale classical and umbrella sampling simulations.
    Bhardwaj VK; Purohit R
    Carbohydr Polym; 2023 Jun; 310():120729. PubMed ID: 36925262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive activity and molecular interactions of irbesartan in complex with 2-hydroxypropyl-β-cyclodextrin.
    Leonis G; Christodoulou E; Ntountaniotis D; Chatziathanasiadou MV; Mavromoustakos T; Naziris N; Chountoulesi M; Demetzos C; Valsami G; Damalas DE; Tzakos AG; Thomaidis NS; Karageorgos V; Liapakis G
    Chem Biol Drug Des; 2020 Jul; 96(1):668-683. PubMed ID: 32691965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the interactions of irbesartan and irbesartan-2-hydroxypropyl-β-cyclodextrin complex with model membranes.
    Liossi ΑS; Ntountaniotis D; Kellici TF; Chatziathanasiadou MV; Megariotis G; Mania M; Becker-Baldus J; Kriechbaum M; Krajnc A; Christodoulou E; Glaubitz C; Rappolt M; Amenitsch H; Mali G; Theodorou DN; Valsami G; Pitsikalis M; Iatrou H; Tzakos AG; Mavromoustakos T
    Biochim Biophys Acta Biomembr; 2017 Jun; 1859(6):1089-1098. PubMed ID: 28274845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and in vitro/in vivo performance of self-nanoemulsifying drug delivery systems loaded with candesartan cilexetil.
    AboulFotouh K; Allam AA; El-Badry M; El-Sayed AM
    Eur J Pharm Sci; 2017 Nov; 109():503-513. PubMed ID: 28889028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New supersaturating drug delivery system as strategy to improve apparent solubility of candesartan cilexetil in biorelevant medium.
    Pinto JMO; Leão AF; Alves GF; Mendes C; França MT; Fernandes D; Stulzer HK
    Pharm Dev Technol; 2020 Jan; 25(1):89-99. PubMed ID: 31583925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of solid-state NMR spectroscopy to study candesartan cilexetil (TCV-116) membrane interactions. Comparative study with the AT1R antagonist drug olmesartan.
    Ntountaniotis D; Kellici T; Tzakos A; Kolokotroni P; Tselios T; Becker-Baldus J; Glaubitz C; Lin S; Makriyannis A; Mavromoustakos T
    Biochim Biophys Acta; 2014 Oct; 1838(10):2439-50. PubMed ID: 24946142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of PAMAM dendrimer concentration, generation size and surface functional group on the aqueous solubility of candesartan cilexetil.
    Ertürk AS; Gürbüz MU; Tülü M
    Pharm Dev Technol; 2017 Feb; 22(1):111-121. PubMed ID: 27484586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of β-Cyclodextrin and Hydroxypropyl-β-Cyclodextrin Inclusions on the Degradation of Magnolol by Intestinal Bacteria.
    Tang L; Zhu Z; Xie M; Cao L; Yu XL; Zhang R; Ou Z; Shan W; Zhang Z
    AAPS PharmSciTech; 2019 Jul; 20(6):244. PubMed ID: 31286296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.